Stock Price Movement and Market Context
On 9 March 2026, Syngene International Ltd’s stock price edged closer to its 52-week low, currently just 4.44% above the lowest price point of Rs 381.05. The stock has experienced a consecutive two-day decline, resulting in a cumulative return loss of -1.19% during this period. Trading volumes and price action have aligned closely with the Healthcare Services sector, which itself has faced downward pressure.
The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend. This technical positioning indicates that the stock has struggled to regain momentum in the short to medium term.
Broader market conditions have also been challenging. The Nifty index closed at 24,028.05, down by 422.4 points or -1.73% on the same day. The index has been on a three-week losing streak, shedding -6.03% in total. Notably, the INDIA VIX index hit a new 52-week high, reflecting increased market volatility and investor caution. All market capitalisation segments have declined, with small caps particularly weak, as the Nifty Small Cap 100 index fell by -2.22%.
Financial Performance and Valuation Concerns
Syngene International Ltd’s financial results have contributed to the subdued investor sentiment. The company reported a Profit Before Tax (PBT) excluding other income of Rs 83.60 crores for the December 2025 quarter, representing a sharp decline of -37.8% compared to the average of the previous four quarters. Similarly, Profit After Tax (PAT) for the quarter stood at Rs 52.29 crores, down by -55.3% relative to the prior four-quarter average. Earnings per share (EPS) also hit a low of Rs 0.37 for the quarter, underscoring the pressure on profitability.
Over the last five years, Syngene’s net sales have grown at an annualised rate of 11.77%, while operating profit has expanded at a more modest 5.36% per annum. This slower profit growth relative to sales has weighed on margins and overall earnings quality.
The company’s return on equity (ROE) stands at 9.9%, which, when combined with a price-to-book value ratio of 3.5, suggests a relatively expensive valuation compared to peers. The stock is trading at a premium to its sector’s historical averages despite the recent earnings decline.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Relative Performance and Market Positioning
Syngene International Ltd has underperformed significantly against benchmark indices. Over the past year, the stock has delivered a negative return of -41.36%, while the Sensex has gained 4.35% in the same period. This underperformance extends over the last three years, with the stock consistently lagging the BSE500 index annually.
Profitability has also deteriorated, with reported profits falling by -18.5% over the last year. This combination of declining earnings and share price has contributed to the company’s current rating status.
On 19 January 2026, Syngene International Ltd’s Mojo Grade was downgraded from Sell to Strong Sell, reflecting the deteriorating fundamentals and valuation concerns. The company’s Mojo Score currently stands at 28.0, indicating a cautious stance on the stock’s near-term prospects.
Balance Sheet and Shareholding Structure
Despite the challenges, Syngene maintains a conservative capital structure with an average debt-to-equity ratio of zero, indicating no reliance on debt financing. This low leverage reduces financial risk and provides some stability amid earnings volatility.
Institutional investors hold a significant stake in the company, with 40.8% of shares owned by these entities. Such holdings suggest that well-resourced investors continue to monitor the company’s fundamentals closely, although this has not translated into price support recently.
Considering Syngene International Ltd? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Summary of Key Metrics
To summarise, Syngene International Ltd’s stock is currently trading near its 52-week low of Rs 381.05, down from a 52-week high of Rs 760. The stock’s recent performance has been in line with sector trends but remains weak relative to broader market indices. Financial results for the December 2025 quarter showed marked declines in profitability, with PBT and PAT falling by -37.8% and -55.3% respectively compared to recent averages.
The company’s valuation metrics, including a price-to-book ratio of 3.5 and ROE of 9.9%, suggest a premium pricing that has not been supported by earnings growth, which has been modest over the past five years. The downgrade to a Strong Sell rating and a Mojo Score of 28.0 reflect these concerns.
While the balance sheet remains strong with no debt and substantial institutional ownership, these factors have not prevented the stock’s decline amid a challenging market environment and subdued financial performance.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
